Laboratory assessment of transthyretin amyloidosis

Merrill D. Benson, Masahide Yazaki, Nadine Magy

Research output: Contribution to journalReview article

16 Scopus citations

Abstract

Mutations in transthyretin (TTR) are the most common cause of autosomal dominant systemic amyloidosis. To date, more than 80 TTR mutations have been associated with amyloidosis in humans. A high prevalence of some mutations like Val122Ile which is identified in 3% of African Americans indicates the necessity of thorough investigation of patients suspected of having, or to be at risk of developing, TTR amyloidosis. Laboratory tests available for evaluation of TTR amyloidosis include both DNA and protein assays. In the case of a known mutation DNA analysis is realized by restriction fragment length polymorphism (RFLP), polymerase chain reaction-induced mutation restriction analysis (PCR-IMRA), single strand confirmation polymorpism (SSCP) or nucleotide sequencing. SSCP, PCR-non-isotopic RNAse cleavage assay (NIRCA) or nucleotide sequencing are used to identify an unknown mutation. At the protein level, two techniques are used, isoelectric focusing and mass spectrometry, in both cases (known or unknown mutation). The identification of a previously unknown mutation requires a combination of clinical, pathological and molecular studies.

Original languageEnglish (US)
Pages (from-to)1262-1265
Number of pages4
JournalClinical Chemistry and Laboratory Medicine
Volume40
Issue number12
DOIs
StatePublished - Dec 1 2002

Keywords

  • Amyloidosis
  • DNA assays
  • Inherited disease
  • Protein analysis
  • Transthyretin

ASJC Scopus subject areas

  • Clinical Biochemistry

Fingerprint Dive into the research topics of 'Laboratory assessment of transthyretin amyloidosis'. Together they form a unique fingerprint.

  • Cite this